AGER and diabetic kidney disease: Long term treatment with the RAGE decoy receptor, sRAGE, has been shown to improve measures of DKD in the db/db model of T2D and obesity [101] and RAGE blockade by antibodies was effective at slowing progression of DKD in models of T1D [262] and T2D [263].